March 2011 Issue of MMM
If you're an advertising agency and I'm on your home page, 100% of the time I'm there to do something other than watch a Flash ...
Market research has jumped to the forefront by helping pharma negotiate with payers and analyze a tsunami of new data
Specialty companies seeking a promotion partner typically look for one that can amplify the brand's reach among high-prescribing PCPs
Social media has gotten so big so fast, and healthcare, has lagged behind. Larry Mickelberg traces its evolution and explains how not to get left ...
Everyday Health co-founder and CEO Ben Wolin is out to build the biggest online health audience, and by some estimates, his Everyday Health is already ...
Pharma industry vets and newbies came together to celebrate the induction of MAHF's three newest members
While industries like retail, hospitality and technology have endeavored to make customer experience a primary driver for innovation, the same cannot be said for most ...
Influenza, like all viruses, has a simple structure. A package of genetic material (in this case RNA), is covered by a protein envelope.
A former Merck exec says it's time to wind down a product advertising arms race that he says hurts pharma firms more than it helps ...
Progenics Pharmaceuticals announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation (OIC), to Salix, beginning in April.
Sunovion Pharmaceuticals is targeting 22,000 psychiatrists in the US, with a sales force of 336 reps, in support of Latuda, an atypical antipsychotic for the ...
Featuring news about Abbott, Aqua Pharmaceuticals, Clinical Data and Viibryd
Med Ed Report
The American Board of Medical Specialties' white paper examining how CME can support its Maintenance of Certification (MOC) requirement raised hackles among some who foresaw ...
An American Journal of Public Health study revealed that only one out of four health-related advocacy groups acknowledges industry funding on its website.
The Alliance for CME (ACME) said it is repositioning itself to be an "all-inclusive education platform" geared toward serving those who educate all healthcare professionals.
Featuring news about NIH, OIG, Pri-Med, American Society for Nutrition, Haymarket Medical Education, Archives of Internal Medicine and ACCME
Elsevier purchased Cancer Information Group's (CIG) oncology journal portfolio for an undisclosed sum.
The Drug Information Association tapped Quintiles' J. Rick Turner as editor-in-chief of Drug Information Journal, the group's flagship journal for members.
Featuring news about Future Science Group, Epocrates and Quadrant HealthCom
In the wake of the insider-trading probe involving Human Genome Sciences, should journals expand disclosure rules for researchers to include ties to the financial community? ...
GlaxoSmithKline and Human Genome Sciences launched a patient community for lupus sufferers and their friends and family, in anticipation of an FDA decision on Benlysta ...
Epilepsy.com launched "My Epilepsy Diary" for Android mobile phone users, an extension of its Epilepsy Therapy Project Clinical Organizer suite of health tools for consumers.
Featuring news about Mylan, Dey Pharma, Levitra and Everyday Health
Vaniqa is an Rx dermatological cream that reduces "unwanted facial hair" in women.
Boehringer Ingelheim is partnering with the Country Music Association for a Tune Up For COPD Songwriting Competition featuring country music stars Billy Ray Cyrus and ...
The FDA approved over-the-counter use of Sanofi-Aventis allergy drug Allegra, paving the way for launch by the French drugmaker's US consumer healthcare unit, Chattem.
Sanofi Pasteur, the vaccines division of Sanofi-Aventis, tapped New York Knicks guard Chauncey Billups as its 2011 spokesperson for Vaccines for Teens, an ongoing educational ...
A print ad for Genentech's Boniva overstated the osteoporosis drug's efficacy, said the FDA's DDMAC in an untitled letter.
Featuring news about Sanofi-Aventis, the NBA, the WNBA, American Diabetes Association, Ogilvy CommonHealth Worldwide and Hologic
Paying Minnesota physicians to participate in marketing surveys is no longer considered illegal.
Kantar Health said it hired Susan Suponcic, PhD, as SVP of global market access.
Interlink Healthcare Communications relocated from Princeton, NJ, to the heart of Manhattan, to make it easier for the shop to recruit top talent, said the ...
Featuring news about Allergan, Pacific Communications, North Shore-LIJ Health System, GCI Health, Spectrum and Biogen Idec
Everything in life is inherently risky. Each day, thousands of people are injured driving on roads or walking on public streets.
Twenty months after telling eye care professionals they should report questionable LASIK vision enhancement ads to the agency, FDA in January disclosed a policy of ...
FDA says it is banking on its regulatory science initiative to reverse a decline in new drug and biologic submissions and approvals seen over the ...
In today's digital marketing landscape, initiating and maintaining relationships with medical professionals requires healthcare agencies to "get into the heads" of this audience. In short, ...
Innovations in healthcare seem to be popping up in new places all the time, including the Consumer Electronics Show (CES) in January.
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Tuesday, October 18, 2016
- Five things for pharma marketers to know: Wednesday, October 19, 2016
- FCB Health's Rich Levy on HIV/AIDS Campaigns that Fight Stigma
- Five things for pharma marketers to know: Monday, October 24, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Sunovion hires former BI exec as VP of marketing
- Merck's Keytruda wins approval in first-line lung cancer
- If Roche's Ocrevus is approved, the already competitive MS market will gain another player
- Top 25 neurology products, based on 2016 sales forecasts